Mitigating Safety Risks in Early Clinical Development

Venue: Crowne Plaza Philadelphia Downtown

Location: Philadelphia, Pennsylvania, United States

Event Date/Time: Nov 08, 2010 End Date/Time: Nov 09, 2010
Registration Date: Nov 08, 2010
Early Registration Date: Sep 17, 2010
Report as Spam


How can we best reduce the risk of severe adverse reactions to marketed drugs? The program will focus on clinical risk assessment and bridging the gap between preclinical data and clinical studies and offer strategies to better assess, predict and mitigate safety risks. Preclinical safety and clinical safety participants and presenters will share challenges with their counterparts on the ‘other side’ in order to educate each other and better understand safety in a context that goes beyond one’s immediate purview.

The special, two-day conference entitled “Mitigating Safety Risks in Early Clinical Development” will address the pressing issues that drug safety experts are facing today. Safety issues can arise throughout the life-history of a drug, from preclinical screening through to the clinic and after launch. Thus, the conference is co-located with our annual “Post-Approval Drug Safety” meeting and will offer shared sessions and networking in order to facilitate inter-disciplinary sharing of ideas in an informal setting. Our hope is that everyone, no matter their role at their company or institute, can learn from those working earlier or later in drug development and that industry can better bridge the gap between preclinical, clinical and post-approval drug safety.


1800 Market Street
United States